CrushSCI.com
94Average days
94Median days
32Fastest days
156Longest days
452025 publications

Paper Review Records

All Paper Review Records

2 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

156 days

CPX-351: From preclinical studies to future directions

Authors
A. Sperotto; G. Ciotti; M. Basso; M. GottardiShow moreShow less
Affiliations
UOSD Terapie Cellulari – Dipartimento di Oncologia, Istituto Oncologico Veneto (IOV) – IRCCS – Padova, Italy; UOC Oncoematolgia – Dipartimento di Oncologia, Istituto Oncologico Veneto (IOV) – IRCCS – Padova, Italy; UOC Farmacia – Dipartimento di Oncologia traslazionale e dei servizi trasversali, Istituto Oncologico Veneto (IOV) – IRCCS – Padova, ItalyShow moreShow less
Source PDF DOI Publisher page
32 days

Real-world evidence supporting orphan drugs approvals for rare neuromuscular disorders in the European Union and the United States: Review of public assessment reports (2015–2025)

Authors
Beliu García-Parra; Josep M. Guiu; Mónica Povedano; Pilar ModamioShow moreShow less
Affiliations
Doctoral Program in Drug Research, Development and Control, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain; Clinical Neurophysiology Section – Neurology Service, Bellvitge University Hospital - Bellvitge Health Sciences Campus, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain; Clinical Pharmacy and Pharmaceutical Care Unit, Department of Pharmacy and Pharmaceutical Technology, and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain; Consortium of Health and Social Care of Catalonia, Barcelona, Spain; Motor Neuron Diseases Unit, Bellvitge University Hospital - Bellvitge Health Sciences Campus, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, SpainShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does CURRENT OPINION IN PHARMACOLOGY take to review a manuscript?

As of 2026-11-19, CrushSCI has 2 complete review records for CURRENT OPINION IN PHARMACOLOGY. The fastest paper went from submission to acceptance in 32 days (Real-world evidence supporting orphan drugs approvals for rare neuromuscular disorders in the European Union and the United States: Review of public assessment reports (2015–2025), received 2025-10-08, accepted 2025-11-09); the slowest took 156 days. The average is 94 days and the median is 94 days. With fewer than 5 records, treat this as indicative only.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.